Metabolon Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Metabolon Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010931
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a blood test performed for detecting early-stage insulin resistance and for obesity related chronic diseases. Metabolon provides metabolomics services for various applications in the areas of research in discovery biology, pharmaceutical research and development, clinical trials, nutrition and consumer goods, and bioprocessing and cell culture science. The company collaborates with research institutions, pharmaceutical, nutrition, agricultural and consumer goods companies for its research activities. It has operations in the UK and the US. Metabolon is headquartered in Durham, North Carolina, the US.

Metabolon Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Metabolon Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolon Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolon Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolon Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolon Inc, Medical Equipment, Deal Details 11
Venture Financing 11
Metabolon Raises USD15 Million in Venture Financing 11
Metabolon Raises USD5 Million in Venture Financing 12
Metabolon Raises US$15 Million In Series E Financing 13
Metabolon Secures US$13 Million In Series D Financing 15
Private Equity 16
Essex Woodlands Management Invests Additional USD15 Million in Metabolon 16
Partnerships 17
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 17
Metabolon Enters into Licensing Agreement with Synlab 18
Muses Labs Partners with Metabolon 19
Metabolon Enters into Co-Development Agreement with Johns Hopkins University and Tufts Medical Center 20
Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 21
Global Genomics Enters Into Agreement With Metabolon For Cardiovascular Disease Biomarkers And Drug Targets 22
Metabolon And Bostwick Lab Enter Into Agreement To Market Prostarix Test 23
Imdea Food Enters Into Agreement With Metabolon To Advance Nutrition-Based Personalized Medicine 24
Metabolon Enters Into Co-Development Agreement With Takeda Pharma 25
Metabolon Enters Into Licensing Agreement With Patia Biopharma For Quantose Prediabetes Test 26
Acquisition 27
Metabolon Acquires Lipomics Technologies, Diagnostics Company 27
Metabolon Inc – Key Competitors 28
Metabolon Inc – Key Employees 29
Metabolon Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Joint Venture 30
Recent Developments 31
Corporate Communications 31
Jan 26, 2017: Metabolon Announces Changes to Executive Leadership Team 31
Other Significant Developments 32
May 03, 2017: Metabolon to Establish Metabolomics Lab in Qatar to Serve Markets in the Middle East 32
Jan 05, 2017: Metabolon to Work With InnVentis to Study Chronic Inflammatory Diseases 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Metabolon Inc, Medical Equipment, Key Facts 2
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Metabolon Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Metabolon Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Metabolon Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Metabolon Inc, Deals By Market, 2011 to YTD 2017 8
Metabolon Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Metabolon Raises USD15 Million in Venture Financing 11
Metabolon Raises USD5 Million in Venture Financing 12
Metabolon Raises US$15 Million In Series E Financing 13
Metabolon Secures US$13 Million In Series D Financing 15
Essex Woodlands Management Invests Additional USD15 Million in Metabolon 16
Zhejiang Dian Diagnostics Enters into Licensing Agreement with Metabolon 17
Metabolon Enters into Licensing Agreement with Synlab 18
Muses Labs Partners with Metabolon 19
Metabolon Enters into Co-Development Agreement with Johns Hopkins University and Tufts Medical Center 20
Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 21
Global Genomics Enters Into Agreement With Metabolon For Cardiovascular Disease Biomarkers And Drug Targets 22
Metabolon And Bostwick Lab Enter Into Agreement To Market Prostarix Test 23
Imdea Food Enters Into Agreement With Metabolon To Advance Nutrition-Based Personalized Medicine 24
Metabolon Enters Into Co-Development Agreement With Takeda Pharma 25
Metabolon Enters Into Licensing Agreement With Patia Biopharma For Quantose Prediabetes Test 26
Metabolon Acquires Lipomics Technologies, Diagnostics Company 27
Metabolon Inc, Key Competitors 28
Metabolon Inc, Key Employees 29
Metabolon Inc, Other Locations 30
Metabolon Inc, Subsidiaries 30
Metabolon Inc, Joint Venture 30

★海外企業調査レポート[Metabolon Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Independent Order of Foresters:企業の戦略的SWOT分析
    The Independent Order of Foresters - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Australian Leaders Fund Limited
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Quantum Fuel Systems LLC (QTWWQ):企業の戦略的SWOT分析
    Quantum Fuel Systems LLC (QTWWQ) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Nanobiotix SA (NANO):企業の製品パイプライン分析
    Summary Nanobiotix SA (Nanobiotix) designs and manufactures nanomedicines for the treatment of cancer. The company is evaluating its lead product candidate NBTXR3 against soft tissue sarcoma, pancreatic, liver, rectal, prostate, head and neck cancers; Non-small cell lung cancer (NSCLC); recurrent he …
  • Genalyte Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genalyte Inc (Genalyte) is a lab testing service provider. The company’s services include data analysis, phlebotomist for blood draw, integration with existing emr, phlebotomist for blood draw, applications for test order and results review and clinical lab scientist. It provides instruments …
  • Wesfarmers Ltd (WES):企業の財務・戦略的SWOT分析
    Wesfarmers Ltd (WES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MEDICREA Group (ALMED):企業の財務・戦略的SWOT分析
    Summary MEDICREA Group (MEDICREA) is a medical equipment company that provides surgical solutions to neurosurgeons and orthopedic surgeons. The company designs, manufactures and distributes proprietary technologies related to patient specific spinal surgery. It offers products such as polyaxial spin …
  • Internet Brands, Inc.:企業のM&A・事業提携・投資動向
    Internet Brands, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Internet Brands, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • GSI Creos Corporation:企業の戦略・SWOT・財務情報
    GSI Creos Corporation - Strategy, SWOT and Corporate Finance Report Summary GSI Creos Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sun Pharma Advanced Research Company Ltd (SPARC):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Mitobridge Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mitobridge Inc (Mitobridge), formerly Mitokyne, Inc. is a drug development company that discovers and develops small molecule therapeutics. The company offers products that enhance the mitochondrial functions. It develops therapies for rare diseases and then expand into more common diseases. …
  • Avangrid Renewables LLC:電力:M&Aディール及び事業提携情報
    Summary Avangrid Renewables LLC (Avangrid Renewables) a subsidiary of Avangrid Renewables Holdings, Inc., is a renewable energy company that carries out electricity generation from renewable energy sources including wind, biomass, solar energy and thermal energy. The company also provides services s …
  • Arise AB (ARISE)-エネルギー分野:企業M&A・提携分析
    Summary Arise AB (Arise) is an independent onshore wind company. It has a presence in the entire value chain from prospecting and permit management to financing, construction, sale, and long-term management of its own and others’ wind farms. The company owns wind plants in southern Sweden; and co-ow …
  • Woodward Inc:戦略・SWOT・企業財務分析
    Woodward Inc - Strategy, SWOT and Corporate Finance Report Summary Woodward Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Weatherford International Plc (WFT):企業の財務・戦略的SWOT分析
    Weatherford International Plc (WFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Akari Therapeutics Plc (AKTX):企業の財務・戦略的SWOT分析
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company. The company is engaged in the development of therapeutic treatments for rare and orphan autoimmune and inflammatory diseases. It offers coversin drugs that act on complement component-C5 that hel …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務情報
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • ConforMIS Inc (CFMS):医療機器:M&Aディール及び事業提携情報
    Summary ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDu …
  • Owlstone Medical Ltd:企業の製品パイプライン分析2018
    Summary Owlstone Medical Ltd (Owlstone Medical), formerly Tiger Dawn Ltd, is a diagnostic company. The company develops and commercializes breathalyzers for use in clinical diagnostics and precision medicines. It offers FAIMS Technology for medical applications; Lonestar for disease biomarker detect …
  • Astrenska Insurance Ltd:企業の戦略・SWOT・財務情報
    Astrenska Insurance Ltd - Strategy, SWOT and Corporate Finance Report Summary Astrenska Insurance Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆